Tinzaparin is a low-molecular-weight heparin (LMWH) with antithrombotic properties. It has FDA-approved labeling for use in the treatment of acute symptomatic deep-vein thrombosis (DVT ...

Small molecules are low molecular weight molecules that include lipids, monosaccharides, second messengers, other natural products and metabolites, as well as drugs and other xenobiotics.

In our study published in the Journal of the American Chemical Society, our team from The University of Hong Kong and ...

Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated ...

Another win for the jab. GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced dementia risk to addiction treatment.

Christopher Schwarzenegger opened up about his dramatic weight loss transformation at the Inaugural Beacher Vitality Happy & Healthy Summit on Saturday, May 10 Christopher, the 27-year-old son of ...

The associate producer—youngest of exes Arnold Schwarzenegger and Maria Shriver’s four kids—recently shared insight into his six-year weight loss journey, including what inspired him to get ...

2:12 Health Matters: Eli Lilly launches single-dose vials weigh- loss drug to expand supply People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50 per cent more weight than those using ...

People considering weight-loss medications might wonder which one works best, and first-of-its-kind research points to an answer. A new study published in the New England Journal of Medicine ...

Zepbound Outperforms Wegovy in Head-to-Head Weight Loss Study MONDAY, May 12, 2025 (HealthDay News) — A new study has found that people taking Eli Lilly’s obesity drug Zepbound lost almost 50% ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.

Mitochondrial overproduction of superoxide activates four major pathways of hyperglycemic damage by inhibiting GAPDH. From Brownlee M: Biochemistry and molecular cell biology of diabetic ...